-
According to a just-released analysis of the latest national sexually transmitted infection (STI) surveillance data, 1.4 million new cases of chlamydia were reported in the United States in 2011.
-
The Food and Drug Administration (FDA) has given clearance to Cepheid of Sunnyvale, CA, to market its Xpert CT/NG test.
-
-
Sterilization continues to be a leading contraceptive choice for women in the United States; between 2006 and 2008, 10.3 million women looked to the method for birth control.
-
The Food and Drug Administration has given approval to Skyla, a new intrauterine system (IUS) from Bayer HealthCare Pharmaceuticals of Wayne, NJ. Available by prescription in February 2013, Skyla is the first new intrauterine contraceptive to receive U.S. approval in more than a decade.
-
-
Contraceptive injectables are a popular form of birth control for women around the world, with more than 35 million women relying on the method.
-
-
Since the July 2002 publication of the first Women's Health Initiative (WHI) report, many changes have been made in the approach to hormone therapy (HT).
-
The ECG shown above was obtained from a 60-year-old man undergoing chemotherapy and radiation therapy for lung cancer.
